Concourse Financial Group Securities, Inc. Better Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share
Q4 2023 Feb 07, 2024	BUY	$0.14 - $0.39 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.34 - $1.23 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.34 - $1.23 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.69 - $1.46 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.64 - $1.45 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.1 - $1.74 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.53 - $2.77 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.91 - $2.34 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.98 - $5.01 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.58 - $17.14 $0 - $0

Others Institutions Holding BTTX

# of Institutions

Shares Held

Call Options Held

Put Options Held

Ancora Advisors, LLC Cleveland, OH

3K
Shares

$0
0.0% of portfolio

View Full List

About Better Therapeutics, Inc.

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

More about BTTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account